HCV NS5A 2209-2248 amino acid substitutions affect serum 2,5AS activities.
Murashima
S
S
Kumashiro
R
R
Ide
T
T
Sata
M
M
D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012367:RNA, Viral / Q000737:chemistry*; D012324:RNA-Dependent RNA Polymerase / Q000737:chemistry*; D017361:Viral Nonstructural Proteins / Q000737:chemistry*
D000998:Antiviral Agents; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins; D007372:Interferons; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase; D015088:2',5'-Oligoadenylate Synthetase